The text provides financial information for Cigna Corporation for the three and nine months ended September 30, including total revenues, benefits, expenses, net income, shareholders' equity, and comprehensive income. It also includes data on assets, liabilities, and operating and investing activities. Additionally, it details reinsurance activities and investments, covering reinsurance recoverables, the impact of reinsurance on income statements, and the exit of GMDB and GMIB business through a reinsurance deal with Berkshire in 2013. The text also elaborates on the Company's investment portfolio, encompassing debt securities, equity securities, commercial mortgage loans, policy loans, long-term investments, short-term investments, and derivative financial instruments, providing a breakdown by category and classification, and specific details on impairments, value changes, and credit loss allowances for debt and equity securities.
The text provides a comprehensive overview of Cigna's financial condition and operational activities, including segments such as Evernorth, U.S. Medical, International Markets, Other Operations, Corporate, and Investment Assets. It delves into aspects like liquidity management, capital resources, critical accounting estimates, and forward-looking statements. Cigna's approach to managing liquidity at various levels, debt obligations, recent acquisitions, and divestitures, shareholder dividends, and capital management strategy are also outlined in detail. Moreover, it addresses non-GAAP financial measures, including adjusted figures for income from operations and revenues in segment analysis, as well as guarantees, contractual obligations, and the significance of realistic financial estimates. The text advises caution in interpreting full-year results based on interim data, emphasizing the need for accurate financial assumptions and awareness of potential impacts on the company's financial health and operational outcomes.
The text explains that the quantitative and qualitative disclosures about market risk are included under the "Market Risk" section in Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, and are incorporated by reference.
The text provided discusses the evaluation of Cigna's disclosure controls and procedures. It mentions that the Chief Executive Officer and Chief Financial Officer of Cigna have concluded that these controls and procedures are effective in ensuring that required information is disclosed accurately and on time. Additionally, it states that there have been no significant changes in internal control over financial reporting that could impact Cigna's operations.
The text sent provides information about legal proceedings regarding "Litigation Matters" and "Regulatory Matters" in the company's Consolidated Financial Statements. It directs readers to Note 15 in the Quarterly Report on Form 10-Q for details on legal proceedings terminated during the quarter ended June 30, 2021.
The text provides information about where to find details on factors that could impact a company's operations, financial situation, and liquidity. It directs individuals to refer to the risk factors discussed in the Annual Report on Form 10-K for the year ending December 31, 2020.
Cigna provided information on its share repurchase activity for the quarter ended September 30, 2021, totaling 10,288,604 shares repurchased. The company disclosed that employees tendered a portion of the shares due to equity compensation plans. Additionally, Cigna maintains a share repurchase program authorized by its Board of Directors, allowing for repurchases based on market conditions and capital usage. The total dollar amount allotted for repurchases was increased to $6.6 billion as of November 3, 2021, and the program allows for various methods of repurchase. The table in the text details the shares purchased, average prices, and remaining value for further repurchases as of the given period.
I am ready to receive the text parts for summarization. Please go ahead and share them with me.
I'm here to help you. Please go ahead and share the text with me so that I can summarize it for you.
The Board of Directors adopted amended by-laws to improve corporate governance practices, including provisions for remote shareholder meetings, clarified rules for meetings, updated procedures for director nominations, and extended the retirement dates for key executives. The retiring executives will receive benefits such as cash incentives, vested stock options, and strategic performance shares. They will also continue to provide advisory services to the company for a specified period.
The text provides a list of exhibits related to Cigna Corporation, including By-Laws, certifications from the CEO and CFO, and financial statements. The last part includes a signature from the Executive Vice President and Chief Financial Officer, Brian C. Evanko, indicating the report has been signed on behalf of Cigna Corporation.
